Quo Vadis Analytical Procedure Development and Validation?
Spectroscopy · 01.09.2022 · 8-14
DOI: 10.56530/spectroscopy.mf9790d5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spectroscopy, online erschienen am 01.09.2022. Verfasst von C. Burgess und 1 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
What do the draft publications ICH Q2(R2) and Q14 for analytical procedure validation and development mean for a regulated Good Manufacturing Practice (GMP) laboratory? Are they consistent with the approach taken by United States Pharmacopoeia (USP) on Analytical Procedure Lifecycle? Why does it take two documents to describe what USP can do in one?
Zitieren
APA
Burgess, C., & McDowall, R. (2022). Quo Vadis Analytical Procedure Development and Validation?. Spectroscopy, 8-14. https://doi.org/10.56530/spectroscopy.mf9790d5
Vancouver
Burgess C, McDowall R. Quo Vadis Analytical Procedure Development and Validation?. Spectroscopy. 2022:8-14. doi:10.56530/spectroscopy.mf9790d5
BibTeX
@article{Burgess2022,
author = {Burgess, C. and McDowall, R.D.},
title = {Quo Vadis Analytical Procedure Development and Validation?},
journal = {Spectroscopy},
year = {2022},
pages = {8--14},
doi = {10.56530/spectroscopy.mf9790d5}
}
EUVIMED